Quan Venture
Venture capitalGrand Cayman · 3 people tracked
Find your way into Quan Venture
Fund manager profile
Quan Venture is a venture fund manager based in Grand Cayman. SEC filings show 2 venture funds on record, most recently Quan Venture Fund III, L.P. ($350M offering) filed August 2021.
Source: SEC EDGAR Form D filings. Firm website data not yet available.
Team · 3 people
from public directoriesWhat they invest in
from 2 of 2 portfolio companiesBiotech ×2Medical Devices ×1
HQs:United States×2
Investments · 2 tracked
founders shown can be your intro path
Design Therapeutics is a biopharmaceutical company developing small molecule therapeutic candidates for serious genetic diseases through its GeneTAC (Gene Targeted Chimera) platform.
BiotechMedical DevicesSolana Beach, US
Pratik Shah, Ph.D.(Executive Officer, Director)Aseem Z. Ansari, Ph.D.(Director)Sean Jeffries, Ph.D.(Executive Officer)
BoardSimeon George, M.D.(Director)Stella Xu, Ph.D.(Director)Rodney Lappe, Ph.D.(Director)
Co-investorsAvoro Capital AdvisorsQuan CapitalRA CapitalSR One Capital ManagementWestRiver Group
Nextcure is a clinical-stage biopharmaceutical company developing immunotherapies targeting IO pathways, with a focus on oncology applications.
BiotechBeltsville, US
Michael Richman(Executive Officer, Director)Timothy Mayer(Executive Officer)inUdayan Guha(Executive Officer)inSteven P. Cobourn(Executive Officer)inSourav Kundu(Executive Officer)inKevin Shaw(Executive Officer)in
Co-investorsBay City CapitalCanaan PartnersLAVLilly Asia VenturesPfizer Venture InvestmentsQuan Capital+4 more
Exits · 2
IPOs and acquisitions across the tracked portfolioPortfolio news
latest coverage across their companiesDesigntx · defenseworld.net · Sep 2, 2026
NextCure · investing.com · Jul 15, 2026
IPO stake values · per SEC filings · 2
Value of this firm's stake in each portfolio company at its IPO price, from the prospectus principal-stockholder table.
| Company | Owned | IPO price | At IPO | Stake value |
|---|---|---|---|---|
| Designtx | 8.8% | $20.00 | Mar 2021 | $94.4M |
| NextCure | 4.1% | $36.75 | Nov 2019 | $40.6M |
Source: SEC S-1 / 424B prospectus filings. Stake value = shares beneficially owned × the initial public offering price, as disclosed — a market value at IPO, not a return multiple (the firm's original cost is not disclosed).
Frequently asked questions
- Where is Quan Venture located?
- Quan Venture is headquartered in Grand Cayman.